Jude Onyia

Companies

• Voyager Therapeutics (United States)Board member Feb 27, 2023 to now¹
• Neurocrine BiosciencesChief Scientific Officer Dec 1, 2021 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Neurocrine Biosciences NBIX22,647 shares³$3.1M at $137.36Sep 11, 2026
• Voyager Therapeutics (United States) VYGR2,910 shares⁴$6.0K at $2.06Feb 27, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 11, 2026Shares withheld for tax 1,936 shares at $156.22 of Neurocrine Biosciences³
• Sep 11, 2026Granted 3,587 shares of Neurocrine Biosciences³
• Aug 4, 2026Gift 2,409 shares of Neurocrine Biosciences⁵
• Jun 5, 2026Gift 2,441 shares of Neurocrine Biosciences⁶
• Jun 1, 2026Sold 11,000 shares at $160.25 of Neurocrine Biosciences⁷
• Jun 1, 2026Exercised options 11,000 shares at $84.74 of Neurocrine Biosciences⁷
• May 27, 2026Sold 11,000 shares at $155.53 of Neurocrine Biosciences⁸
• May 27, 2026Exercised options 11,000 shares at $84.74 of Neurocrine Biosciences⁸
• Feb 20, 2026Gift 3,110 shares of Neurocrine Biosciences⁹
• Feb 13, 2026Shares withheld for tax 10,755 shares at $124.12 of Neurocrine Biosciences¹⁰
• Feb 13, 2026Granted 19,935 shares of Neurocrine Biosciences¹⁰
• Feb 13, 2026Shares withheld for tax 1,466 shares at $124.12 of Neurocrine Biosciences¹⁰
• Feb 13, 2026Exercised options 2,717 shares of Neurocrine Biosciences¹⁰
• Feb 13, 2026Shares withheld for tax 1,452 shares at $124.12 of Neurocrine Biosciences¹⁰
• Feb 13, 2026Exercised options 2,690 shares of Neurocrine Biosciences¹⁰
• Feb 12, 2026Shares withheld for tax 1,426 shares at $123.10 of Neurocrine Biosciences¹⁰
• Feb 12, 2026Exercised options 2,560 shares of Neurocrine Biosciences¹⁰
• Jan 31, 2026Shares withheld for tax 142 shares at $136.06 of Neurocrine Biosciences¹¹
• Jan 31, 2026Exercised options 238 shares of Neurocrine Biosciences¹¹
• Nov 29, 2025Shares withheld for tax 2,248 shares at $152.16 of Neurocrine Biosciences¹²
• Nov 29, 2025Exercised options 4,426 shares of Neurocrine Biosciences¹²
• Sep 3, 2025Gift 1,470 shares of Neurocrine Biosciences¹³
• Aug 5, 2025Gift 3,116 shares of Neurocrine Biosciences¹⁴
• Jul 9, 2025Sold 59,819 shares at $130.46 of Neurocrine Biosciences¹⁵
• Jul 9, 2025Exercised options 59,819 shares at $84.74 of Neurocrine Biosciences¹⁵